2025. EFFICACY OF NEWER GLP-1 RECEPTOR AGONISTS ON NON-ALCOHOLIC FATTY LIVER DISEASE IN TYPE 2 DIABETES. The Research of Medical Science Review. 3, 5 (May 2025), 290–294.